Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. November 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa Announces Multiple Patiromer for Oral Suspension Abstracts to be Presented at American Society of Nephrology Annual Meeting 2014

REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that data from clinical trials of the company's lead product candidate,...
03. November 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa Names Scott Garland Senior Vice President and Chief Commercial Officer

REDWOOD CITY, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that Scott Garland has joined the company as senior vice president and chief commercial officer....
30. Oktober 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa to Present at Nomura Biotechnology Conference

REDWOOD CITY, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that management will present at the Nomura Biotechnology Conference...
22. Oktober 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa Submits New Drug Application to U.S. FDA Seeking Approval for Patiromer for Oral Suspension to Treat Hyperkalemia

REDWOOD CITY, Calif., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug...
16. Oktober 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on October 15, 2014, the compensation committee of the company's...
30. September 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa to Present at the 13th Annual BIO Investor Forum

REDWOOD CITY, Calif., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate...
18. September 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa to Present at Newsmakers in the Biotech Industry

REDWOOD CITY, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate...
16. September 2014 16:00 ET | Quelle: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on September 15, 2014, the compensation committee of the...
15. September 2014 18:45 ET | Quelle: Relypsa, Inc.

Relypsa Announces New Analysis of Phase 3 Data Demonstrating Patiromer's Ability to Rapidly Correct, and Prevent Recurrence of, Hyperkalemia in Heart Failure and Non-Heart Failure Patients

REDWOOD CITY, Calif., Sept. 15, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that data in heart failure (HF) patients from its pivotal Phase 3...
09. September 2014 08:00 ET | Quelle: Relypsa, Inc.

Relypsa Announces Commercial Manufacturing Agreement With Patheon, Inc.

REDWOOD CITY, Calif., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that it has entered into a multi-year commercial manufacturing and...

Vorherige Seite

Nächste Seite